carbapenems has been researched along with gabexate in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (gabexate) | Trials (gabexate) | Recent Studies (post-2010) (gabexate) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 743 | 53 | 106 |
| Protein | Taxonomy | carbapenems (IC50) | gabexate (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 0.9 | |
| Coagulation factor X | Homo sapiens (human) | 4.61 | |
| Plasminogen | Homo sapiens (human) | 0.431 | |
| Urokinase-type plasminogen activator | Homo sapiens (human) | 0.431 | |
| Serine protease hepsin | Homo sapiens (human) | 0.383 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, T; Eguchi, S; Hidaka, M; Matsushima, H; Ono, S; Soyama, A; Takatsuki, M | 1 |
1 other study(ies) available for carbapenems and gabexate
| Article | Year |
|---|---|
Efficacy of Triple-Drug Therapy to Prevent Pancreatic Fistulas in Patients With High Drain Amylase Levels After Pancreaticoduodenectomy.
Topics: Adult; Aged; Aged, 80 and over; Amylases; Carbapenems; Drug Therapy, Combination; Gabexate; Humans; Middle Aged; Octreotide; Pancreatic Fistula; Pancreaticoduodenectomy; Postoperative Complications; Retrospective Studies | 2019 |